Abstract:Teshager Worku Kegne, 1, &ast Zelalem Alamrew Anteneh, 2, &ast Tadios Lidetu Bayeh, 2, &ast Birhanu Melaku Shiferaw, 3, &ast Desiyalew Habtamu Tamiru 4, &ast 1 Department of Health Services, Management Sciences for Health, Addis Ababa, Ethiopia; 2 Department of Epidemiology and Biostatistics, School of Public Health, Bahir Dar University, Bahir Dar, Ethiopia; 3 Department of Public Health, Gamby Medical and Business College, Bahir Dar, Ethiopia; 4 Department of Public Health Emergency, Humedica e.V International Aid Organization, Addis Ababa, Ethiopia &astThese authors contributed equally to this work Correspondence: Desiyalew Habtamu Tamiru, Tel +251912717030, Email Background: Tuberculosis and human immunodeficiency virus co-infection pose a major public health concern, particularly in developing countries. The survival and predictors of mortality were not sufficiently studied among TB-HIV co-infected patients in Ethiopia. Objective: This study aimed to investigate the survival rate and predictors of mortality among TB-HIV co-infected patients during TB treatment at public health facilities in Bahir Dar, Northwest Ethiopia. Methods: A retrospective follow-up study was conducted among 401 TB-HIV co-infected patients who were treated for tuberculosis between July 2018 and June 2022 at public health facilities in Bahir Dar city, Ethiopia. Data were collected using a structured checklist from patient charts. Data entry and analysis were done using EpiData 3.1 and Stata version 15, respectively. A Cox proportional Hazard regression model was used to identify predictors of mortality. Predictors with P < 0.05 in the multivariable regression were considered statistically significant. Results: Among the 401 TB-HIV co-infected patients, 59 (14.7%) died during the follow-up period. Predictors like lower BMI (AHR = 3.00, 95% CI = 1.44, 6.28), extrapulmonary TB infection (AHR = 3.30, 95% CI = 1.50, 7.29), presence of opportunistic infection (AHR = 5.07, 95% CI = 2.55, 10.08), functional status (bedridden: AHR = 4.49, 95% CI = 1.63, 12.33), and adherence to TB treatment (fair = AHR = 2.74, 95% CI = 1.41, 7.20, and poor = AHR = 3.75, 95% CI = 1.52, 9.23) were associated with mortality. Conclusion: Mortality among TB and HIV coinfected people was high at public health facilities in Bahir Dar city. This result suggested that in order to increase patient survival, it would be necessary to enhance nutritional status, increase adherence to TB treatment, and prevent opportunistic infections. Keywords: TB, HIV, mortality, predictors, retrospective, survival, Ethiopia Tuberculosis (TB) and the Human Immunodeficiency Virus (HIV) are among the leading public health problems globally. Tuberculosis is one of the most common illnesses and causes of death among people living with HIV (PLWHIV). HIV positive individuals have a 20–30 times greater risk of contracting TB than HIV negative individuals due to lowered immunity. Reports also indicated that PLWHIV are more likely to develop active TB than HIV negative. 1,2 The global TB report 2021 stated that out of ten million people infected with TB, 8% were PLHIV. The proportion of TB episodes coinfected with HIV was highest in the African region, exceeding 50% in parts of Southern Africa. 2 TB and HIV form a lethal combination, each speeding the other's progress. As a result, individuals with co-infections of TB and HIV have a significant risk of increased mortality. Without proper treatment, 60% of HIV-negative people with TB on average and nearly all HIV-positive people with TB will die. 3 Globally, 1.6 million people died from TB and 1 million from HIV in 2017 and accounting for one in every 300,000 deaths from both diseases. 1 Most recently, about one-third of all AIDS-related deaths worldwide are caused by TB, which is the leading cause of death among HIV-positive individuals. An estimated 167,000 people died from TB-HIV coinfection in 2022. 3 The syndromic interaction between TB and HIV has played a ruinous role, with Africans bearing a disproportionate share of the burden. In 2019, people in Africa accounted for 73% of TB-HIV co-infection cases and 81% of all TB-HIV deaths. At the country level, South Africa and Nigeria rank among the worst affected in sub-Saharan Africa and globally for both diseases. 4,5 In addition to TB disease, PLHIV bears a high burden of drug-resistant TB strains; thus, if diagnosis is delayed, there is an increased risk of mortality from multidrug-resistant and extensively drug-resistant TB in this population. 6</ -Abstract Truncated-

HIV co-infection increases the risk of post-tuberculosis mortality among persons who initiated treatment for drug-resistant tuberculosis

HIV co-infection increases the risk of post-tuberculosis mortality among persons who initiated treatment for drug-resistant tuberculosis

Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in southern China: a cohort study

Survival Rate and Predictors of Mortality Among TB-HIV Co-Infected Patients During Tuberculosis Treatment at Public Health Facilities in Bahir Dar City, Northwest Ethiopia

A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipality

Factors related to in-hospital deaths in patients co-infected with human immunodeficiency virus and tuberculosis

[The influence of comorbidities on treatment outcomes in patients with tuberculosis]

Factors associated with time to death among HIV/TB co-infected patients on ART in Dire Dawa, Ethiopia: A retrospective study

Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008-2019

Incidence rate of mortality and its predictors among tuberculosis and human immunodeficiency virus coinfected patients on antiretroviral therapy in Ethiopia: systematic review and meta-analysis

Population differences in death rates in HIV-positive patients with tuberculosis.

Incidence Rate and Risk Factors for Developing Active Tuberculosis Among People Living With HIV in Georgia 2019-2020 Cohort

Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study

Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil

Association of treated and untreated chronic hepatitis C with the incidence of active tuberculosis disease: a population-based cohort study.

Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis

Lack of weight gain and increased mortality during and after treatment among adults with drug-resistant tuberculosis in Georgia, 2009-2020

Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)–Coinfected Patients With High HBV Replication

Mycobacterium tuberculosis and human immunodeficiency virus co-infection and associated variables among presumptive pulmonary tuberculosis patients in Ethiopia; a health institution based cross-sectional study

Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa

Clinical and Epidemiological Characteristics of COVID-19 in Persons Living with HIV Complicated by Tuberculosis